Tissue- and Serum-Derived Exosomal microRNAs as Predictors of Neoadjuvant Chemotherapy Response in Breast Cancer

Clinical trial NCT07500129 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07500129
Sponsor: Atlas University
Status: NOT_YET_RECRUITING
Study type: OBSERVATIONAL

Breast Cancer Invasive Breast Carcinoma Exosomal microRNA Neoadjuvant Chemotherapy Response Pathological Complete Response

Start date: 2026-04-12
Primary completion: 2027-01-15
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.